OTCMKTS:SHPMF Shanghai Pharmaceuticals (SHPMF) Stock Price, News & Analysis $1.41 0.00 (0.00%) As of 09/21/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Shanghai Pharmaceuticals Stock (OTCMKTS:SHPMF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SHPMF alerts:Sign Up Key Stats Today's Range$1.39▼$1.4150-Day Range$1.41▼$1.4652-Week Range$1.46▼$1.53VolumeN/AAverage Volume33,943 shsMarket CapitalizationN/AP/E Ratio1.51Dividend Yield18.70%Price TargetN/AConsensus RatingN/A Company Overview Shanghai Pharmaceuticals (OTCMKTS: SHPMF) is a leading integrated healthcare company headquartered in Shanghai, China. Established in 1994 through the consolidation of state‐owned pharmaceutical entities, the firm has built a comprehensive business model spanning pharmaceutical distribution, manufacturing and retail pharmacy services. The company’s core distribution network delivers prescription and over‐the‐counter medications, medical devices and healthcare products to hospitals, clinics and community pharmacies across mainland China. In its manufacturing segment, Shanghai Pharmaceuticals produces active pharmaceutical ingredients (APIs), finished dosage forms and chemical intermediates. The company’s research and development arm focuses on both generic and innovative therapies, with a pipeline that addresses major therapeutic areas such as cardiovascular, oncology and central nervous system disorders. With multiple production sites certified to international quality standards, Shanghai Pharmaceuticals supports domestic demand and exports to select Asian and African markets under strategic partnerships. On the retail side, the company operates a chain of community pharmacies under the “Shanghai Pharma” brand, providing healthcare advice, prescription fulfillment and wellness services to end users. Over the years, Shanghai Pharmaceuticals has pursued targeted acquisitions and alliances to strengthen its supply‐chain capabilities and broaden its product offering. Led by an experienced executive team and overseen by a board of directors with deep industry expertise, the company continues to expand its footprint in China’s healthcare sector and enhance its R&D and commercial platforms.AI Generated. May Contain Errors. Read More Receive SHPMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SHPMF Stock News HeadlinesShanghai Pharmaceuticals Sets Record Date and Tax Terms for 2026 Interim DividendSeptember 3, 2026 | tipranks.comShanghai Pharmaceuticals Announces Interim Cash Dividend for First Half of 2026August 27, 2026 | tipranks.com$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its entire military budget. Central banks have bought over 1,000 tonnes of gold a year for three years running, trading paper for metal.September 22 at 1:00 AM | American Alternative (Ad)Shanghai Pharmaceuticals Revises Vote Data on 2025 Profit Distribution PlanJuly 8, 2026 | tipranks.comShanghai Pharmaceuticals Sets Final 2025 Dividend and Details HK Tax TreatmentJune 25, 2026 | tipranks.comShanghai Pharmaceuticals Details Board Line-Up and Governance CommitteesJune 25, 2026 | tipranks.comShanghai Pharmaceuticals Updates 2025 Final Dividend and Tax ArrangementsJune 3, 2026 | tipranks.comShanghai Pharmaceuticals Sets Board Meeting to Approve Q1 2026 ResultsApril 17, 2026 | tipranks.comSee More Headlines SHPMF Stock Analysis - Frequently Asked Questions How have SHPMF shares performed this year? Shanghai Pharmaceuticals' stock was trading at $1.46 at the beginning of 2026. Since then, SHPMF stock has decreased by 3.5% and is now trading at $1.4084. How do I buy shares of Shanghai Pharmaceuticals? Shares of SHPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:SHPMF CIK1570300 Webwww.sphchina.com Phone86-21-6373-0908FaxN/AEmployees49,234Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio1.51 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:SHPMF) was last updated on 9/22/2026 by MarketBeat.com Staff. From Our PartnersThe Shiller CAPE ratio now sits above 41. Before the 1929 crash, it was 32.6.The Shiller CAPE ratio now sits above 41 a level seen only once before, near the peak of the dot-com bubble. B...USA Capital Gold | Sponsored$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | SponsoredChina's dominance in rare earth processing sparks new defense rulesOn January 1, 2027, new Pentagon rules tighten sourcing restrictions on critical minerals tied to foreign adve...The Tomorrow Investor | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredA councilman backed AI — then 13 bullets hit his front doorThirteen bullets hit an Indianapolis councilman's front door days after he backed a data center rezoning. Acro...Stansberry Research | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Pharmaceuticals Holding Co., Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Pharmaceuticals With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.